Molecular Vision for Surgery.
Amyno is building targeted fluorescent imaging agents to show surgeons critical anatomy by its molecular identity. We are currently developing and validating our first agent in the laboratory.

Some of the most important structures are the hardest to see.
Surgeons depend on telling anatomy apart from the tissue around it, but visual contrast is limited, especially for small, delicate structures. When something goes wrong, the result can be lifelong and expensive complications.
Today’s fluorescent dyes mostly show where fluid or dye travels. Amyno’s agents are designed to bind a structure’s own molecular markers, so the signal shows the structure itself.
Built to extend beyond a single structure.
Our first agent targets lymphatic vessels. The same approach is intended to reach nerves, ureters, bile ducts, blood vessels, and other critical anatomy.
Technology like ours is meant to make today’s surgeries safer and to help enable the future of autonomous robotic surgery.
Building the next layer of surgical visualization.
We welcome conversations with clinicians, researchers, and potential collaborators interested in molecular imaging.
Contact Amyno